Baruch Samuel Blumberg | Academic Influence

Baruch Samuel Blumberg's AcademicInfluence.com Rankings

Baruch Samuel Blumberg

Philosophy

#1199

World Rank

#2230

Historical Rank

#494

USA Rank

Logic

#1110

World Rank

#1762

Historical Rank

#361

USA Rank

philosophy Degrees

Download Badge

Philosophy

Baruch Samuel Blumberg's Degrees

Bachelors Physics Union College, New York

Why Is Baruch Samuel Blumberg Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Baruch Samuel Blumberg , known as Barry Blumberg, was an American physician, geneticist, and co-recipient of the 1976 Nobel Prize in Physiology or Medicine , for his work on the hepatitis B virus while an investigator at the NIH and at the Fox Chase Cancer Center. He was president of the American Philosophical Society from 2005 until his death.

(See a Problem?)

Baruch Samuel Blumberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A "NEW" ANTIGEN IN LEUKEMIA SERA. (1965) (1243)
A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. (1967) (616)
The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives (2003) (404)
Particles associated with Australia Antigen in the Sera of Patients with Leukaemia, Down's Syndrome and Hepatitis (1968) (387)
Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. (2005) (345)
EFFECT OF PHYLLANTHUS AMARUS ON CHRONIC CARRIERS OF HEPATITIS B VIRUS (1988) (304)
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. (1999) (295)
Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. (1987) (286)
Moderate elevation of body iron level and increased risk of cancer occurrence and death (1994) (286)
Australia antigen and the biology of hepatitis B. (1977) (234)
An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. (1969) (223)
Hepatitis and leukemia: their relation to Australia antigen. (1968) (213)
Australia antigen as a hepatitis virus. Variation in host response. (1970) (212)
An isoprecipitation reaction distinguishing human serum-protein types. (1961) (211)
The relation of infection with the hepatitis B agent to primary hepatic carcinoma. (1975) (201)
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. (1994) (179)
Usage and bioassays in Phyllanthus (Euphorbiaceae). IV. Clustering of antiviral uses and other effects. (1995) (178)
Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome. (1968) (160)
Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans. (1969) (157)
Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. (1988) (154)
Haptoglobin Types in British, Spanish Basque and Nigerian African Populations (1958) (152)
Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking (1998) (145)
Australia antigen and acute viral hepatitis. (1969) (141)
HOST RESPONSES TO HEPATITIS-B INFECTION IN PATIENTS WITH PRIMARY HEPATIC CARCINOMA AND THEIR FAMILIES A Case/Control Study in Senegal, West Africa (1976) (133)
Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. (1997) (127)
Additional Specificities of Australia Antigen and the Possible Identification of Hepatitis Carriers (1969) (126)
Australia antigen and hepatitis. (1970) (125)
ARA NOMENCLATURE AND CLASSIFICATION OF ARTHRITIS AND RHEUMATISM (TENTATIVE). (1964) (123)
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver. (1997) (117)
Australia Antigen detected in the Nuclei of Liver Cells of Patients with Viral Hepatitis by the Fluorescent Antibody Technique (1969) (115)
Iron-binding proteins and risk of cancer in Taiwan. (1986) (111)
Family studies of a human serum isoantigen system (Australia antigen). (1966) (110)
Landmark article Feb 15, 1965: A "new" antigen in leukemia sera. By Baruch S. Blumberg, Harvey J. Alter, and Sam Visnich. (1984) (107)
POLYMORPHISMS OF THE SERUM PROTEINS AND THE DEVELOPMENT OF ISO-PRECIPITINS IN TRANSFUSED PATIENTS. (1964) (102)
Antigen Polymorphism of a Low-Density Beta-Lipoprotein. Allotypy in Human Serum (1962) (93)
Inherited antigenic differences in human serum beta lipoproteins. A second antiserum. (1963) (93)
Australia antigen in chronic active liver disease with cirrhosis. (1969) (91)
ANTIBODY TO HEPATITIS-B CORE ANTIGEN IN PATIENTS WITH PRIMARY HEPATIC CARCINOMA (1975) (87)
SELECTION, GENE MIGRATION AND POLYMORPHIC STABILITY IN A U. S. WHITE AND NEGRO POPULATION. (1963) (86)
Lack of perinatal transmission of hepatitis B virus infection in Senegal, West Africa. (1985) (84)
Association between lepromatous leprosy and Australia antigen. (1967) (84)
Sex distribution of Australia antigen. (1972) (82)
Further studies on a "new" human isoprecipitin system (Australia antigen). (1966) (80)
Host responses to hepatitis B infection in patients in a chronic hemodialysis unit. (1977) (80)
The dynamics of hepatitis B virus infection. (1996) (78)
Hepatitis B virus and the prevention of primary hepatocellular carcinoma. (1981) (78)
Serum ferritin as a predictor of host response to hepatitis B virus infection. (1983) (78)
Thyroxine-serum protein complexes in various animals. (1962) (77)
Uses and bioassays in Phyllanthus (Euphorbiaceae): a compilation. II. The subgenus Phyllanthus. (1991) (74)
DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome. (1970) (74)
AUSTRALIA ANTIGEN (A HEPATITIS-ASSOCIATED ANTIGEN) PURIFICATION AND PHYSICAL PROPERTIES (1970) (73)
Hepatitis B virus and primary hepatocellular carcinoma: Family studies in Korea (1982) (72)
Increased serum ferritin in chronic liver disease: A risk factor for primary hepatocellular carcinoma (1989) (69)
Caenorhabditis elegans survives atmospheric breakup of STS-107, space shuttle Columbia. (2005) (69)
Viral hepatitis, postnecrotic cirrhosis, and hepatocellular carcinoma. (1969) (69)
Geographical Distribution of Australia Antigen Determinants d, y and w (1974) (68)
THE LOCALIZATION OF AUSTRALIA ANTIGEN BY IMMUNOFLUORESCENCE (1970) (68)
Records of usage or assays in Phyllanthus (Euphorbiaceae). I. Subgenera Isocladus, Kirganelia, Cicca and Emblica. (1990) (66)
Australia antigen and hepatitis. (1970) (64)
Changes in serum iron levels due to infection with hepatitis B virus. (1981) (64)
Albumin Naskapi: A New Variant of Serum Albumin (1966) (63)
Hepatitis B virus and primary hepatocellular carcinoma: treatment of HBV carriers with Phyllanthus amarus. (1990) (62)
Hepatitis B virus and hepatocellular carcinoma--treatment of HBV carriers with Phyllanthus amarus. (1989) (61)
The effect of sialidase on transferrins and other serum proteins (1961) (60)
Possible Polymorphism of Bovine α-Lactalbumin (1958) (60)
Distribution of Electrophoretically Different Haemoglobins among Some Cattle Breeds of Europe and Africa (1958) (59)
Serum albumin and mortality (1990) (59)
Association of graft survival with host response to hepatitis B infection in patients with kidney transplants. (1977) (58)
Production of Antibody against “Australia Antigen” in Rabbits (1966) (58)
Hepatitis B virus and sex ratio of offspring. (1978) (56)
A human lipoprotein polymorphism. (1962) (55)
A study of the prevalence of arthritis in alaskan eskimos (1961) (54)
Hepatitis B virus and the prevention of primary cancer of the liver. (1985) (54)
Multiple Antigenic Specificities of Serum Lipoproteins Detected with Sera of Transfused Patients (1964) (52)
Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited. (1997) (51)
Hepatitis B and the Sex Ratio at Birth: A Comparative Analysis of Four Populations (1988) (50)
NOMENCLATURE AND CLASSIFICATION OF ARTHRITIS AND RHEUMATISM (TENTATIVE) ACCEPTED BY THE AMERICAN RHEUMATISM ASSOCIATION. (1964) (50)
Epidemiology of hepatitis B virus infection in the rural community of Tip, Senegal. (1987) (49)
Light-scattering studies on hyaluronic acid. (1954) (47)
Australia antigen (a hepatitis-associated antigen) in leukemia. (1970) (46)
Transient "bisalmuminemia" induced by drugs. (1968) (46)
Gm Phenotypes and Genotypes in U. S. Whites and Negroes; in American Indians and Eskimos; in Africans; and in Micronesians. (1961) (46)
Letter: Cross-reaction of antibodies to human lactoferrin with HBAg. (1974) (45)
Pathogenesis of posttransfusion viral hepatitis in children with β‐thalassemia (1994) (45)
Frequency of Australia antigen in patients with leukaemia in different countries. (1971) (45)
Australia Antigen–Antibody Complexes (1970) (45)
Haemoglobin types in Greek populations (1963) (44)
HEPATITIS-B VIRUS IN BEDBUGS (CIMEX HEMIPTERUS) FROM SENEGAL (1977) (44)
Viral hepatitis and tests for the Australia (hepatitis-associated) antigen and antibody. (1970) (42)
A newly identified hepatitis B type virus in tree squirrels. (1986) (42)
Biochemical Polymorphisms in Animals (1960) (40)
THE HAPTOGLOBINS AND HAEMOGLOBINS OF ALASKAN ESKIMOS AND INDIANS (1959) (40)
Radioimmunoprecipitation Assay for Australia Antigen, Antibody, and Antigen-Antibody Complexes 1 (1971) (40)
Haptoglobins and Transferrins of two Tropical Populations (1961) (39)
Thyroxine-serum protein complexes: single dimension gel and paper electrophoresis studies. (1960) (39)
X antigen/antibody markers in hepadnavirus infections. Presence and significance of hepadnavirus X gene product(s) in serum. (1990) (38)
AUSTRALIA ANTIGEN, HEPATITIS VIRUS AND DOWNS SYNDROME * (1970) (38)
A Mechanism for Liver Cell Injury in Viral Hepatitis: Effects of Hepatitis B Virus on Neutrophil Function in Vitro and in Children with Chronic Active Hepatitis (1983) (37)
Australia antigen: a genetic basis for chronic liver disease and hepatoma? (1971) (37)
The NASA Astrobiology Institute: early history and organization. (2003) (37)
Silent Maternal Transmission of Australia Antigen (1974) (37)
Albumin Mexico, a New Variant of Serum Albumin (1967) (37)
The curiosities of hepatitis B virus: prevention, sex ratio, and demography. (2006) (36)
Deficiency of erythrocyte glucose‐6‐phosphate dehydrogenase in Greek populations (1963) (35)
Susceptibility to leukemia: immunologic factors in Down's syndrome. (1971) (35)
Australia antigen and viral hepatitis in drug abusers. (1971) (34)
Familial osteoarthropathy of the fingers. (1958) (34)
Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning. (1987) (34)
Transmission of hepatitis B associated with hemodialysis: role of malfunction (blood leaks) in dialysis machines. (1976) (34)
Australia antigen: physical and chemical properties. (1971) (34)
Virus-like particles in Australia antigen-associated hepatitis. An immunoelectron microscopic study of human liver. (1972) (33)
Ergasteric hepatitis: endemic hepatitis associated with Australia antigen in a research laboratory. (1971) (33)
Association of hepatitis b virus infection with hepatocellular carcinoma in american patients (1980) (33)
The effects of proteolytic enzymes on the hyaluronic acid complex of ox synovial fluid. (1957) (32)
Hepatitis B virus and sex ratio of offspring in East Greenland. (1986) (31)
Effects of host and environment on immunoglobulins in Down's syndrome. (1969) (31)
Application of an automated tandem high-performance liquid chromatographic system to peptide mapping of genetic variants of human serum albumin. (1986) (31)
Specificities of Human Antibodies to Australia Antigen 1 (1970) (31)
THE NATURE OF AUSTRALIA ANTIGEN AND ITS RELATION TO ANTIGEN-ANTIBODY COMPLEX FORMATION (1971) (30)
Iron-binding proteins, hepatitis B virus, and mortality in the Solomon Islands. (1983) (30)
Serum ferritin concentration and recurrence of colorectal adenoma. (2000) (30)
Tree squirrel hepatitis B virus: antigenic and structural characterization. (1986) (29)
The serum alkaline phosphatase of pregnancy. (1966) (29)
X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis. (1995) (29)
Blood groups of Alaskan Eskimos and Indians. (1959) (29)
Australia Antigen: Detection and Transmission in Shellfish (1974) (29)
Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa. (1977) (29)
Sex differences in response to hepatitis B virus. I. History. (1979) (28)
The haptoglobins, hemoglobins and serum proteins of the Alaskan fur seal, ground squirrel and marmot. (1960) (27)
Modelling the impact of mass vaccination against hepatitis B. I. Model formulation and parameter estimation (1994) (27)
Hepatitis B virus: pathogenesis and prevention of primary cancer of the liver. (1982) (26)
In vitro activity of phyllanthus (Euphorbiaceae) species against the DNA polymerase of hepatitis viruses: Effects of growing environment and inter- and intra-specific differences (1991) (25)
Australia antigen and hepatitis. Studies in asymptomatic people and lepromatous leprosy patient. (1970) (25)
Serum iron levels and response to hepatitis B virus (1979) (25)
Reduction of post‐transfusion hepatitis by exclusion of Australia antigen from donor blood in an urban public hospital (1974) (25)
Autosomal Linkage between the Albumin and Gc Loci in Humans (1967) (25)
Hepatitis B surface antigen (Australia antigen) in parents and sex ratio of offspring in a Greek population. (1975) (25)
Lymphocyte function in normal people with persistent Australia antigen. (1973) (25)
Relationship of Human Anti-lipoprotein Allotypic Sera (1964) (24)
Physicochemical properties of hyaluronic acid formed by Streptococcus haemolyticus. (1958) (24)
Usage and bioassays in Phyllanthus (Euphorbiaceae): a compilation. III. The subgenera Eriococcus, Conami, Gomphidium, Botryanthus, Xylophylla and Phyllanthodendron, and a complete list of the species cited in the three-part series. (1992) (24)
Further evidence on the protein complexes of some hyaluronic acids. (1958) (24)
Alterations in haptoglobin levels. (1963) (23)
Hepatitis B virus and sex ratio on Kar Kar Island. (1982) (23)
The Daedalus effect: changes in ethical questions relating to hepatitis B virus. (1985) (23)
Letter: Elevated serum iron levels and persistent Australia antigen (HBsAG). (1974) (23)
The Production of Antibodies to Australia Antigen in Mouse Ascites Fluid 1 (1970) (23)
Interaction of fucoidan from Pelvetia fastigiata with surface antigens of hepatitis B and woodchuck hepatitis viruses. (1989) (22)
BIOCHEMICAL POLYMORPHIC TRAITS IN A U. S. WHITE AND NEGRO POPULATION. (1963) (22)
The genetically determined serum hepatoglobins in rheumatoid arthritis. (1958) (22)
THE GENETICS OF HUMAN SERUM ALBUMIN††This work was supported by USPHS Grants CA-06551, RR-05539 and CA-06927 from the National Institutes of Health, and by an appropriation from the Commonwealth of Pennsylvania. (1977) (21)
Decreased survival of HTLV-I carriers in leprosy patients from the Democratic Republic of the Congo: a historical prospective study. (1997) (21)
Hepatitis B: The Hunt for a Killer Virus (2002) (21)
Genetics of Albumin Gainesville, a New Variant of Human Serum Albumin (1969) (21)
IRON AND IRON BINDING PROTEINS IN PERSISTENT GENERALISED LYMPHADENOPATHY AND AIDS (1984) (21)
Loci differentially affected by selection in two American black populations. (1971) (21)
Albumin Naskapi variant in North American Indians and Eti Turks. (1980) (21)
Australia Antigen and Antibody in Transfused Children with Thalassaemia* (1972) (20)
Biological Sciences: Association of Antibodies to Australia Antigen with Anti-Gm Antibodies in Italian Patients with Thalassaemia (1972) (20)
Australia antigen and hepatitis: a comprehensive review. (1971) (20)
ISO‐ANTIBODIES IN HUMANS AGAINST INHERITED SERUM LOW DENSITY BETA‐LIPOPROTEINS, THE AG SYSTEM (1963) (20)
Persistent anicteric hepatitis with Australia antigen in patients with Down's syndrome. (1972) (20)
Phyllantus Species: Sources of New Antiviral Compounds (2000) (20)
The Australia antigen in Brazilian healthy persons and in leprosy and leukaemia patients (1970) (20)
Alloalbuminemia. Albumin Naskapi in Indians of the Ungava. (1968) (20)
Distribution of albumin variants Naskapi amd Mexico among Aleuts, Frobisher Bay Eskimos, and Micmac, Naskapi, Mohawk, Omaha, and Apache Indians. (1978) (20)
Hepatitis-B antigen in colony mosquitoes. (1973) (19)
Lymphocyte Transformation and Hepatitis I. Impairment of Thymidine Incorporation and DNA Polymerase Activity 1 (1971) (19)
Hepatitis B surface antigen (Australia antigen) in mosquitoes collected in Senegal, West Africa. (1976) (19)
Dominance and recessivity in medical genetics. (1958) (18)
Precore and X region mutants in hepatitis B virus infections among renal dialysis patients (1995) (18)
Serum iron levels and response to hepatitis B virus. (2000) (18)
Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection. (1991) (18)
Pathogenesis of posttransfusion viral hepatitis in children with beta-thalassemia. (1994) (18)
Astrobiology, space and the future age of discovery (2011) (18)
Isoantibodies to inherited types of β-lipoproteins (Ag) and immunoglobulins (Gm and Inv) (1968) (18)
LEPROMATOUS LEPROSY AND AUSTRALIA ANTIGEN WITH COMMENTS ON THE GENETICS OF LEPROSY. (1970) (18)
Inherited susceptibility to disease. Its relation to environment. (1961) (18)
Primary hepatocellular carcinoma and hepatitis B virus. (1982) (18)
Virus-like particles in Australia antigen-associated hepatitis. (1972) (18)
Coalescence of caudal vertebrae in the giant dinosaur Diplodocus. (1961) (18)
Viral hepatitis. Revised concepts as a result of the study of Australia antigen. (1970) (17)
Urinary Excretion of β-Amino-isobutyric Acid in Eskimo and Indian Populations of Alaska (1959) (17)
Albumin Polymorphism (Albumin Naskapi) in Eskimos and Navajos (1968) (16)
Australia antigen, posttransfusion hepatitis, and the chronic carrier state. (1972) (16)
The selective solvation of the hyaluronic acid complex of ox synovial fluid. (1956) (16)
Localization of the amino acid substitution site in a new variant of human serum albumin, albumin Mexico-2. (1980) (16)
e Antigen in hepatitis B virus infected dialysis patients: assessment of its prognostic value. (1978) (16)
Australia antigen and lepromatous leprosy studies in South India and elsewhere. (1970) (16)
Terbutaline and ephedrine in asthmatic children. (1977) (16)
Geographical variation of the "w" subtype of Australia antigen. (1973) (16)
Australia antigen in the Solomon Islands. (1974) (16)
Proceedings of the Conference on Genetic Polymorphisms and Geographic Variations in Disease (1961) (16)
Primary and secondary prevention of liver cancer caused by HBV. (2010) (16)
Genetics and rheumatoid arthritis (1960) (16)
The role of Australia antigen in viral hepatitis and other diseases. (1972) (15)
Correlation between liver iron content and magnetic resonance imaging in rats. (1989) (15)
Detection of Australia Antigen in Human Tissue Culture Preparations 1 (1971) (15)
Hepatitis B surface antigen, fertility and sex ratio: implications for health planning. (1976) (15)
Bernard Connor (1666-1698) and his contribution to the pathology of ankylosing spondylitis. (1958) (14)
The blood groups of the pastoral Fulani of Northern Nigeria and the Yoruba of Western Nigeria (1961) (14)
The discovery of the hepatitis B virus and the invention of the vaccine: A scientific memoir (2002) (14)
Antilipoprotein Nuoro Serum (C.P.) and its Relation to Sera C. de B. and L.L. (1967) (14)
Synovial stimulatory protein fragments copurify with woodchuck hepatitis virus: implications for the etiology of arthritis in chronic hepatitis B virus infection. (2001) (13)
High Prevalence of High-Level β-Amino-isobutyric Acid Excretors in Micronesians (1959) (13)
Serum protein polymorphisms among the Peruvian Cashinahua. (1969) (13)
Medical survey of Rongelap people five and six years after exposure to fallout (with an addendum on vegetation). (1960) (13)
Raised IgE levels in beta-thalassaemia: correlation with splenectomy and hepatitis B virus infection. (1984) (13)
Does rapid oligomerization of hepatitis B envelope proteins play a role in resistance to proteasome degradation and enhance chronicity? (2006) (13)
Ted Slavin's blood and the development of HBV vaccine. (1985) (13)
Bernard Connor's description of the pathology of ankylosing spondylitis. (1958) (12)
Commercialising University Research: Threats and Opportunities--The Oxford Model (2008) (12)
Electrophoresis of thyroxine in protein-free solutions and in sera deficient in binding proteins. (1962) (12)
The Blood Groups of The Spanish Basques (1957) (12)
Role of glycan processing in hepatitis B virus envelope protein trafficking. (1998) (12)
Serum protein polymorphisms in Greek populations (1964) (12)
Comments on the role of epidemiology in the investigation of hepatitis B virus. (1985) (11)
Thyroid antibodies and Australia antigen in Down's syndrome. (2010) (11)
Cross reactivity between hepatitis B surface antigen and a male-associated antigen. (1978) (11)
BLOOD GROUPS OF THE NASKAPI AND MONTAGNAIS INDIANS OF SCHEFFERVILLE, QUEBEC. (1964) (11)
Study design for a hepatitis B vaccine trial. (1976) (11)
Conjectures on inherited susceptibility to lepromatous leprosy. (1966) (11)
Loss of Immunologic Reactivities of Australia Antigen After Incubation with Bacteria (1973) (11)
Hepatitis B virus and the control of hepatocellular carcinoma. (1984) (11)
Changes in the physical characteristics of the hyaluronate of ground substance with alterations in sodium chloride concentration. (1955) (11)
Alloalbuminemia and the migrations of native Americans (1988) (10)
Australia antigen in mosquitoes. Feeding experiments and field studies. (1973) (10)
A cellular model to explain the pathogenesis of infection by the hepatitis B virus. (1994) (10)
The variety of responses within a community to infection with Australia (hepatitis B) antigen. (1975) (10)
Feasibility of controlling or eradicating the hepatitis B virus. (1989) (10)
X region deletion mutants associated with surface antigen-positive hepatitis B virus infections. (1995) (10)
Heredity of gout and hyperuricemia. (1965) (10)
Gamma-Globulin, Group Specific, and Lipoprotein Groups in a U.S. White and Negro Population (1964) (10)
NEUTROPHEL FUNCTION IN CHILDREN WHO ARE CARRIERS OF HEPATITIS-B SURFACE ANTIGEN (1977) (9)
Prevalence of hbeag and anti‐hbe in chronic active hepatitis, cirrhosis and primary hepatocellular carcinoma in korea (1985) (9)
Blood Polymorphisms and the Origins of New World Populations (2000) (9)
Liver biopsies in patients with and without Australia antigen. (1972) (9)
Bioethical questions related to hepatitis B antigen. (1976) (8)
Hepatitis B virus and hepatocellular carcinoma (1984) (8)
A Cellular Model of the Role of Hepatitis B Virus in the Pathogenesis of Primary Hepatocellular Carcinoma (2000) (8)
Genes, viruses, and the immune response. (1971) (8)
Albumin cartago: a "new" slow-moving alloalbumin. (1972) (8)
New Immunologic Relationships of Australia Antigen 1 (1970) (8)
Viruses similar to hepatitis B virus (Icrons). (1981) (8)
A program for eradication of hepatitis B from Taiwan by a 10-year, four-dose vaccination program (1996) (8)
Obituary: Joshua Lederberg (1925–2008) (2008) (7)
Hepatitis B surface antigen and polymerized albumin binding activity in sheep serum. (1984) (7)
A controlled study of polymorphisms in serum globulin and glucose-6-phosphate dehydrogenase deficiency in leprosy. (1968) (7)
The current state of the prevention of HBV infection, the carrier state and hepatocellular carcinoma. (1997) (7)
Study of the Ag(z) Factor (1967) (7)
New specificity of Australia antigen. (1972) (7)
Down's Syndrome. Two Types Distinguished by a Serum Antigen (Australia Antigen). (1967) (7)
Co‐occurrence of anti‐Ag and anti‐Australia Antibodies in Transfused Patients (1970) (7)
Lymphocyte Transformation and Hepatitis II. Lack of Direct in Vitro Inhibition by Purified Australia Antigen 1 (1971) (7)
Alloalbuminemia in North India. (1982) (7)
Analysis of a cellular model to account for the natural history of infection by the hepatitis B virus and its role in the development of primary hepatocellular carcinoma. (1992) (7)
Lymphocyte transformation and persistent Australia antigen. (1973) (7)
Genetic factors in the population of Plati, Greece. (1983) (7)
Australia antigen and hepatitis. (1970) (7)
Possible polymorphism of bovine alpha-lactalbumin. (1958) (7)
Non-A, non-B hepatitis. (1977) (7)
Comparison of progeny of mothers with and without Australia antigen. (1972) (6)
AUSTRALIA ANTIGEN (A HEPATITIS-ASSOCIATED ANTIGEN) (1970) (6)
Australia antigen and primary biliary cirrhosis (1973) (6)
Alloalbuminemia in Southwestern United States Indians. Polymorphism of Albumin Naskapi and Albumin Mexico (1969) (6)
Comparison of Different Isoprecipitin Sera (1967) (6)
STUDIES ON INHERITED VARIANTS OF BLOOD PROTEINS. II. FAMILIAL SEGREGATION OF TRANSFERRIN B1-2B2. (1963) (6)
Sex-related differences in transmission of hepatitis B infection in a Melanesian population. (1984) (6)
Hepatitis viruses and hepatocellular carcinoma : approaches through molecular biology and ecology (1985) (5)
Australia antigen, hepatitis and susceptibility to leukemia. (1970) (5)
International Conference on Prospects for eradication of hepatitis B virus (1990) (5)
The epidemiology of alloalbuminemia. (1969) (5)
Isoantibodies to inherited types of beta-lipoproteins (Ag) and immunoglobulins (Gm and Inv). Serological and clinical aspects. (1968) (5)
Alloalbuminemia in southwestern U.S. indians: polymorphism of albumin Naskapi and albumin Mexico. (1969) (5)
Neutrophil function in children who are carriers of hepatitis-B surface antigen. (1977) (5)
AN ALKYLATING AGENT FOR MULTIPLE MYELOMA: MELPHALAN. (1965) (5)
Studies of parents of children with acute leukemia. (1975) (5)
Adaptation to infectious disease. Australia antigen and hepatitis. (1970) (5)
Hepatitis B infection and the prevention of primary hepatocellular carcinoma: studies in Senegal. (1981) (4)
HEPATITIS B VIRUS INFECTION IN INFANTS OF ANTI-HBs(+) MOTHERS (1981) (4)
Serum alkaline phosphatase types in North American indians and negroes. (1967) (4)
GOITER IN GANDHARA. A REPRESENTATION IN A SECOND TO THIRD CENTURY AD FRIEZE. (1964) (4)
Lessons Learned from the NASA Astrobiology Institute (2009) (4)
A new precipitating antigen-antibody system [(Pennsylvania antigen) in human serum. (1968) (4)
Scientific process and the hepatitis b virus (1994) (4)
Australia Antigen: Persistence of Immunological Markers (d, y, w) in Antigen Carriers (1973) (4)
Australia antigen,hepatitis and leukemia.(A summary) (1968) (4)
The Princess & the Patriot: Ekaterina Dashkova, Benjamin Franklin, and the Age of Enlightenment (2006) (4)
The Curiosities of Hepatitis B Virus (2012) (4)
Hepatitis B: The Virus, the Disease, and the Vaccine (1984) (4)
Practical applications of the Australia antigen test. (1971) (4)
Use of ranked migration estimates for detecting natural selection. (1974) (4)
Incidence of antibodies against beta-lipoproteins (Ag system), and the factors influencing isoimmunisation in transfused patients in the U.S.A. and Italy. (1967) (4)
`Hepatitis B Virus, Iron and Iron-Binding Proteins (1986) (4)
Australia antigen and the quest for a hepatitis virus (1969) (4)
Serological studies on populations associated with Australia antigen. (1972) (3)
The hepatitis B virus. (1980) (3)
Hepatitis B x antigen and polymerase antibodies in the serum of hepatitis B carriers with or without hepatitis delta virus infection. Effects of interferon treatment. (1992) (3)
The NASA Astrobiology Institute Virus Focus Group Workshop and Field Trip to Mono and Mammoth Lakes, CA, June 22-24, 2004. (2005) (3)
The nature of Australia antigen and its relation to antigen-antibody complex formation. (1971) (3)
Reduced Hepatitis After Blood Transfusion by Australia Antigen Testing of Donor Blood. (1971) (3)
Eradication strategies for HBV: Discussion, part 2 (1990) (3)
Serum lipoprotein allotypes in man. (1965) (3)
Physicochemical Studies on Hyaluronic Acids (2008) (3)
Susceptibility to Australia Antigen Hepatitis in Leukemia. (1969) (3)
The natural history of Australia antigen. (1974) (3)
Australia antigen (HBsAg) carriers in a Greek community. Studies of transaminase (SGPT) levels. (1975) (3)
Hepatic carcinoma. (1987) (3)
Glucose tolerance in Down's syndrome. (1974) (2)
HTLV-I (PHILADELPHIA, 1969) (1989) (2)
Association of Antibodies to Gm and Antibodies to Australia Antigen in Adolescent Drug Addicts (1974) (2)
Hepatitis B Virus and Primary Cancer of the Liver (1986) (2)
Precipitin Activity in the Sera of Patients with Deficiency of β-Lipoproteins (Acanthocytosis) (1965) (2)
Part 2: Hepatitis B infection and human behavior. (1982) (2)
Medical Status of Marshall Islanders in 1959, Five Years after Exposure to Fallout Radiation (1961) (2)
Acute and Persistent Australia Antigen in Drug Users. (1970) (2)
Comments on Scientific Process in Clinical Research (2015) (2)
Session 7. Astrovirology (2008) (2)
Australia antigen in Zaïre. Studies on leprosy. (1973) (2)
A New Variant of Transferrin from Greece (1964) (2)
Australia antigen and hepatitis: recent observations on the serum protein polymorphism, infectious agent hypotheses. (1972) (2)
The history of arthritis and rheumatism (1960) (2)
Susceptibility to persistence of Australia antigen. (1975) (2)
A "New" Antigen inLeukemia Sera (2015) (1)
Current status of Australia antigen. (1972) (1)
Erythrocyte glucose-6 phosphate dehydrogenase (G6PD) and Australia antigen hepatitis in Down's syndrome. (1970) (1)
[Prospects for vaccination against hepatitis B]. (1978) (1)
Hepatitis B infection and kidney-graft survival. (1978) (1)
Studies on inherited variants of blood proteins. 1. Two dimentional electrophoretic analysis of chromatographic fractions of serum proteins. (1962) (1)
Antibody to Australia antigen in an outbreak of hepatitis on an Indian reservation. (1973) (1)
The urinary excretion of beta-amino-isobutyric acid in Pacific populations. (1961) (1)
Sex-related aspects of hepatitis B infection and its consequences (2000) (1)
Keynote Address: The Australia Antigen Story (1984) (1)
High prevalence of high-level beta-amino-isobutyric acid excretors in Micronesians. (1959) (1)
Comments on the prevention of hepatitis B infection in India (2004) (1)
Hepatitis Carriers Among Soldiers Who Have Returned from Vietnam. Australia Antigen Studies (1974) (1)
An epidemiologic approach to inherited disease susceptibility. (1961) (1)
Lymphocyte function in mothers of patients with Down's syndrome. (1971) (1)
Science literacy, policy, evaluation, and other essays (1990) (1)
[The relation of infection with the hepatitis B-agent to primary hepatic carcinoma (author's transl)]. (1976) (1)
A program for eradication of hepatitis B (1996) (1)
The Hepatitis Viruses: Accomplishments and Problems (1994) (1)
Immunofluorescent identification of Australian antigen. (1973) (1)
Hepatitis B and the Prevention of Primary Cancer of the Liver: Selected Publications of Baruch S Blumberg (2000) (1)
The Evolution of Life on Earth and in the Universe (2006) (1)
Hepatitis B Virus and the Carrier Problem (2020) (1)
GENETIC AND ENVIRONMENTAL EFFECTS ON DISEASE: ON “ASSOCIATION” IN THE STUDY OF DISEASE ETIOLOGY * (1972) (1)
The nature of Australia antigen: infectious and genetic characteristics. (1972) (1)
Glucosidase/protein folding inhibitors as possible mutation-proof, anti-hepatitis B & C agents (2003) (0)
AN ADDRESS UNION COLLEGE BICENTENNIAL CELEBRATION.: FOUNDATION DAY (2000) (0)
Reagent and method for detection of hepatitis b (1979) (0)
Scientific and artistic process (2000) (0)
I Volume 11 of Essays of an Information Scientist , with a Foreword by (1990) (0)
INHERITED SERUM PROTEIN VARIANTS WITH EMPHASIS ON ISOPRECIPITINS AND THE BETA LIPOPROTEINS. (1965) (0)
[24] Estimation of genetic heterogeneity in primate T-cell lymphoma/leukemia viruses by PCR (1995) (0)
PRECIPITATING ANTIBODIES IN THE SERA OF TRANSFUSED PATIENTS: POSSIBLE CONFUSION WITH ANTI‐AU (1974) (0)
A memorial oration – Alexander George Ogston, MA (Oxon), DPhil, FRS, FAA (2000) (0)
Research Organizations for Discovery (2003) (0)
Hepatitis: The Plight of the Carrier (1978) (0)
Appendix 1. Scientists and Staff at Fox Chase Cancer Center Referred to in the Text (2002) (0)
Australia antigen: what it means in everyday practice. (1973) (0)
Albumin Naskapi variant in North American Indians and Eti Turks: (albumin B/albumin Mersin/albumin Adana/Central Asia) (2000) (0)
1. A Case History of Plant-Derived Drug Research: Phyllanthus and Hepatitis B Virus (1998) (0)
A LETTER FROM OXFORD (2000) (0)
Baruch Blumberg--hepatitis B and beyond. Interviewed by Pam Das. (2002) (0)
and Lepromatous Leprosy Patient (2017) (0)
BLOOD TRANSFUSION AND THE DISCOVERY OF VIRUSES (2000) (0)
[Hepatitis B and the prevention of hepatocellular carcinoma]. (1982) (0)
Hepatitis B virus and the prevention and control of liver cancer. (2010) (0)
Investigation of the nature of Australia antigen (1975) (0)
Factors affecting survival in patients with cancer of the breast. A preliminary study. (1973) (0)
Ethics and cancer therapy. (1993) (0)
Hepatitis B surface antigen and polymerized albumin binding activity in sheep serum ( anti-hepatitis B surface antigen / hepatitis B binding substance / anti-polymerized albumin / Ausab assay / IgM ) (0)
II SELECTED PUBLICATIONS: BIBLIOGRAPHY (2000) (0)
Chapter 8. The Control of Posttransfusion Hepatitis (2002) (0)
Complexity and the hepatitis viruses. (1994) (0)
[Contribution of blood groups to the study of the anthropology of the Basques]. (1957) (0)
Panel Discussion: Viruses and Autoimmune Disease (1971) (0)
Reagent deep for pruefung the hb sa deep g antigen, as well as process for its manufacture (1979) (0)
Hepatitis B surface antigen and polymerized albumin binding (0)
Procedure for the treatment of retroviral infections (1990) (0)
Hepatitis B virus and the pathogenesis and prevention of cancer of the liver. (1983) (0)
Chapter 3. Polymorphisms and Geography: Disease, Genetics, and Evolutionary Biology (2002) (0)
Prevalence of Australia antigen in military population. (1975) (0)
Joint lubrication. (1958) (0)
Chapter 4. We Discover a New Polymorphism: The Ag System (2002) (0)
Australia Antigen and inherited susceptibility to disease. (1973) (0)
Using 1,5-dideoxy-1,5-imino-d-glucitol n-alkyl derivatives for the treatment of hepatitis B infections (1994) (0)
Prevalence of Australia Antigen in Various Military Populations. (1973) (0)
Serum Alkaline Phosphatase Types in North American Indians and Negroes 99 (2006) (0)
[Hereditary factors in relation to uterine cancer]. (1965) (0)
Viruses and Cancer: A Historical Perspective – HBV and Prevention of a Cancer (2012) (0)
Chapter 2. Oxford and the National Institutes of Health: Inherited Variation and Susceptibility to Disease (2002) (0)
Letter from Baruch S. Blumberg to Joshua Lederberg (1971) (0)
Australia Antigen and the Prevention of Posttransfusion Hepatitis (1985) (0)
Proceedings of the International Conference on Prospects for Eradication of Hepatitis B Virus. Geneva, 23-24 February 1989. (1990) (0)
Complex Interactions of Hepatitis B Virus with Its Host and Environment (2000) (0)
Nutritional status of patients with end stage renal disease influence of chronic hepatitis b virus infection (1984) (0)
4. Hepatitis B virus and hepatocellular carcinoma (1984) (0)
Goiter in Gandhara-Reply (1965) (0)
[Editorial: The Australia antigen]. (1974) (0)
DIFFERENCES IN THE FREQUENCY OF DISEASE IN DIFFERENT POPULATIONS. (1965) (0)
Name Member Type Year Elected to Membership Date of Death (2011) (0)
Australia Antigen andAntibody inTransfused Children with Thalassaemia (1972) (0)
BOOK REVIEWS (2000) (0)
I INTRODUCTORY ESSAY (2000) (0)
Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of infections Hepatitis B Virus. (1994) (0)
From Australia antigen to eradication programs (2004) (0)
Astrobiology: Process and Discovery (2004) (0)
Synovial fluid in arthritis. (1958) (0)
United States Patent 19 Blumberg et al . ( 54 ) HEPATITIS BTESTING REAGENT AND METHOD 75 Inventors : (2017) (0)
The Oxford model: The threats and opportunities of commercializing university research (2008) (0)
Reflections on the Future of Medical Science: The Jayne Lecture (1997) (0)
Astronomical exploration and the public imagination (2009) (0)
Australia antigen--an introduction to this special issue. (1972) (0)
Hepatitis B Virus and Vaccine (1995) (0)
Hepatitis B (2018) (0)

This paper list is powered by the following services:

Other Resources About Baruch Samuel Blumberg

en.wikipedia.org

What Schools Are Affiliated With Baruch Samuel Blumberg?

Baruch Samuel Blumberg is affiliated with the following schools:

Image Attributions

Image Source for Baruch Samuel Blumberg